Having reviewed the baseline functional stroke scale scores reported by Woei-Cherng Shyu and associates, 1 I cannot share the excitement displayed by Cesar Borlongan and David Hess in their accompanying commentary.
2 The methodologic limitations of such a small phase 1 study are addressed in the commentary, but I have an additional concern: the 3 patients in the control group were significantly more impaired at the outset than the 7 patients who were randomly assigned to receive the treatment. It is well recognized that presenting impairment, as measured with scales such as the European Stroke Scale (ESS), the ESS Motor Subscale and the Barthel Index, is a strong predictor of ultimate outcome for stroke patients, 3-5 regardless of treatment. It is therefore crucial to recognize that patients presenting with the greatest of impairments are likely to improve least; conversely, those with milder impairments are more likely to improve more rapidly and more completely.
6,7
Thus, it is not surprising that the 7 patients who were treated (who on average had more than 10% better stroke scale scores at recruitment) ultimately fared better than the 3 patients in the control group.
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